AI & Machine Learning Acquisitions in New Jersey
Showing 4 transactions.
-
November 10, 2025
- Buyer
- Tradespace
- Target
- Paragon
- Industry
- AI & Machine Learning
- Location
- New Jersey, United States
- Type
- Buyout
Tradespace has acquired Paragon, an AI-driven patent-drafting startup founded by Princeton computer science students, to integrate Paragon’s transparent, traceable patent-drafting technology into its IP management platform. The deal brings Paragon’s founding team into Tradespace and positions Tradespace as an AI-powered platform supporting the full intellectual property lifecycle, accelerating patent drafting and reducing time and cost for corporate, university, and independent inventors.
-
June 10, 2025
- Buyer
- Trivest Partners
- Target
- FROM Digital, Algoworks Solutions
- Industry
- AI & Machine Learning
- Location
- New Jersey, United States
- Type
- Addon
Private equity firm Trivest Partners has completed a merger combining FROM Digital and Algoworks Solutions to form the newly branded Algoworks, an AI-native engineering services and experience-transformation firm. Derek Harrar was appointed CEO to lead the integrated business, which serves large enterprise and Fortune 500 clients across multiple regions.
-
September 10, 2024
- Buyer
- Scutum North America, Scutum Group
- Target
- Visentry
- Industry
- AI & Machine Learning
- Location
- New Jersey, United States
- Type
- Addon
Scutum North America, part of the Scutum Group, has integrated Visentry — an AI-powered remote guarding and video monitoring company based in Englewood, New Jersey — into its U.S. business to expand its technology-enabled security offering. The deal adds Visentry’s AI surveillance and remote response capabilities to Scutum’s 360° security and fire protection portfolio as an add-on to the group’s North America platform.
-
February 6, 2023
- Buyer
- ZS
- Target
- Trials.ai
- Industry
- AI & Machine Learning
- Location
- New Jersey, United States
- Type
- Buyout
Global consulting and technology firm ZS has entered into a definitive agreement to acquire Trials.ai, an AI-powered clinical study design company. The acquisition will integrate Trials.ai's intelligent study-design capabilities into ZS's clinical development offerings to help sponsors identify risks, optimize participant experience and accelerate therapy development timelines.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.